Ace inhibitors and angiotensin receptor blockers
1 paper1 finding
- 1 lab in 3 countries
- Funders: Medical Research Future Fund and 2 more
- Humans1
Outcomes
1Mortality
downin humans1HR 0.71
1 study
Mortality
downin humans1HR 0.71
Ace inhibitors and angiotensin receptor blockers decrease mortality in humans (HR 0.71, 95% CI 0.56-0.91).
“ACEi/ARBs (HR 0.71; 95 % CI 0.56 - 0.91), aspirin (HR 0.74; 95 % CI 0.57 - 0.96), and beta-blockers (HR 0.76; 95 % CI 0.58 - 0.98) had a significantly lower 1-year post-discharge mortality”
Humansgeriatric rehabilitation inpatients, after adjusting for Charlson Comorbidity Index56% femalesn = 1,890
Use of potential gerotherapeutic drugs and mortality in geriatric rehabilitation inpatients: RESORT
Mechanisms of ageing and development18 Feb 2026
Latest
1 in 12 monthsMechanisms of Ageing and Development
Use of potential gerotherapeutic drugs and mortality in geriatric rehabilitation inpatients: RESORT
Cohort study of 1,890 peopleInterventions